Apolipeptides TRIZ Cases
- Anti-OxLDL Antibody Therapy for Psoriasis and Atherosclerosis
Targeting oxidized LDL with an ApoB100-binding antibody reduces psoriasis severity while lowering atherosclerosis risk.
- APOE Gene Therapy Vector for APOE4 Suppression in Alzheimer's
AAV delivery of protective APOE variants suppresses APOE4 activity and reduces amyloid and tau burden in Alzheimer's disease.
- Glycoprotein Glycan Control via Copper, Manganese, and pH Shifts
Copper, manganese, pH 7.0, and a temperature shift tune afucosylation and galactosylation without harming cell growth or productivity.
- Artificial Lipid Droplet Preparation for Pure Composition Analysis
Artificial adiposomes mimic lipid droplets without organelle contamination, enabling cleaner in vitro composition studies and drug carrier design.
- Apolipoprotein Fusion Protein for Targeted Lipid Drug Delivery
Apolipoprotein fused with a targeting protein improves lipid carrier binding and receptor-specific drug delivery while reducing off-target side effects.
- ApoL1-Targeting Multispecific Antibodies for Cancer Cell Killing
Multispecific antibodies raise ApoL1 complex uptake into cancer cells, driving cell death as an alternative to resistant myeloma therapies.
- Cas13 AAV Multiplex Gene Silencing for Hypercholesterolemia
rAAV delivery of Cas13 and multi-gRNA cassettes silences liver targets such as PCSK9 to lower cholesterol in statin-resistant patients.
- Telodendrimer Apolipoprotein Nanodiscs for Reduced Aggregation
Hybrid nanodiscs combine apolipoprotein, lipids, and telodendrimers to reduce aggregation while improving solubility and membrane protein stability.